Capital Group Private Client Services Inc. Has $1.47 Million Stock Position in Elevance Health, Inc. $ELV

Key Points

• Capital Group Private Client Services cut its Elevance stake by 93.2% in Q3, selling 61,852 shares and retaining 4,536 shares worth about $1.47 million at quarter-end.
• Other major institutions (Vanguard, Sanders, Artisan, First Eagle and Norges Bank) boosted or initiated positions, leaving institutional ownership at 89.24% of the company.
• Sell‑side sentiment is mildly positive with an average rating of "Moderate Buy" and an average target of $390.55; Elevance recently beat EPS estimates, reported 9.6% revenue growth, and raised its quarterly dividend to $1.72 (annual $6.88, ~2.4% yield).

Capital Group Private Client Services Inc. cut its position in Elevance Health, Inc. (NYSE:ELV - Free Report) by 93.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,536 shares of the company's stock after selling 61,852 shares during the quarter. Capital Group Private Client Services Inc.'s holdings in Elevance Health were worth $1,466,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of ELV. Vanguard Group Inc. grew its position in shares of Elevance Health by 0.6% in the third quarter. Vanguard Group Inc. now owns 22,998,645 shares of the company's stock valued at $7,431,322,000 after purchasing an additional 141,747 shares during the last quarter. Sanders Capital LLC lifted its position in shares of Elevance Health by 24.7% during the 2nd quarter. Sanders Capital LLC now owns 5,825,208 shares of the company's stock worth $2,265,773,000 after purchasing an additional 1,152,440 shares during the last quarter. Artisan Partners Limited Partnership boosted its stake in Elevance Health by 24.5% during the 3rd quarter. Artisan Partners Limited Partnership now owns 4,576,805 shares of the company's stock valued at $1,478,857,000 after purchasing an additional 901,626 shares during the period. First Eagle Investment Management LLC grew its holdings in Elevance Health by 25.0% in the 3rd quarter. First Eagle Investment Management LLC now owns 3,998,603 shares of the company's stock valued at $1,292,029,000 after buying an additional 798,457 shares during the last quarter. Finally, Norges Bank acquired a new stake in Elevance Health in the 2nd quarter valued at approximately $1,148,379,000. Institutional investors own 89.24% of the company's stock.

Wall Street Analysts Forecast Growth

ELV has been the subject of a number of research analyst reports. Robert W. Baird upped their price target on Elevance Health from $297.00 to $340.00 and gave the stock a "neutral" rating in a report on Thursday, December 11th. TD Cowen restated a "buy" rating on shares of Elevance Health in a research note on Wednesday, November 26th. UBS Group set a $400.00 target price on shares of Elevance Health in a research note on Thursday, January 29th. Truist Financial reduced their price target on shares of Elevance Health from $400.00 to $390.00 and set a "buy" rating for the company in a report on Monday, February 2nd. Finally, Royal Bank Of Canada lowered shares of Elevance Health from an "outperform" rating to a "sector perform" rating and set a $358.00 price target on the stock. in a research report on Tuesday, February 3rd. Twelve research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $390.55.

Elevance Health Stock Performance

ELV opened at $282.92 on Wednesday. The stock's 50 day simple moving average is $341.97 and its 200-day simple moving average is $334.91. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.70. The stock has a market cap of $62.44 billion, a PE ratio of 11.26, a P/E/G ratio of 1.55 and a beta of 0.51. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $458.75.

Elevance Health (NYSE:ELV - Get Free Report) last issued its earnings results on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, topping the consensus estimate of $3.10 by $0.23. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The firm had revenue of $49.31 billion during the quarter, compared to analysts' expectations of $49.52 billion. During the same period last year, the business earned $3.84 earnings per share. Elevance Health's quarterly revenue was up 9.6% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Sell-side analysts forecast that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th will be issued a dividend of $1.72 per share. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from Elevance Health's previous quarterly dividend of $1.71. Elevance Health's payout ratio is 27.23%.

Elevance Health Company Profile

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.